UK markets closed

Cardiol Therapeutics Inc. (CRDL.TO)

Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
2.9300+0.2200 (+8.12%)
At close: 04:00PM EDT
Currency in CAD

Valuation measures4

Market cap (intra-day) 200.03M
Enterprise value 165.27M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)7.08
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.41

Trading information

Stock price history

Beta (5Y monthly) 0.68
52-week change 3295.95%
S&P500 52-week change 326.27%
52-week high 33.0500
52-week low 30.7400
50-day moving average 32.4199
200-day moving average 31.6144

Share statistics

Avg vol (3-month) 3157.74k
Avg vol (10-day) 3148.87k
Shares outstanding 568.27M
Implied shares outstanding 668.27M
Float 865.19M
% held by insiders 14.42%
% held by institutions 113.04%
Shares short (30 Apr 2024) 4244.47k
Short ratio (30 Apr 2024) 42.52
Short % of float (30 Apr 2024) 40.37%
Short % of shares outstanding (30 Apr 2024) 40.36%
Shares short (prior month 28 Mar 2024) 469.43k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-37.71%
Return on equity (ttm)-69.93%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -29.59M
Net income avi to common (ttm)-28.13M
Diluted EPS (ttm)-0.4400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)34.93M
Total cash per share (mrq)0.51
Total debt (mrq)174.34k
Total debt/equity (mrq)0.62%
Current ratio (mrq)4.36
Book value per share (mrq)0.43

Cash flow statement

Operating cash flow (ttm)-25.18M
Levered free cash flow (ttm)-14.99M